Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For:	Lawrence S. Shift toward early-stage deals favors biotechs. Nat Biotechnol 2006;24:6. [PMID: 16404377 DOI: 10.1038/nbt0106-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]

Number	Cited by Other Article(s)
1	Lähteenmäki R, Lawrence S. Public biotechnology 2005—the numbers. Nat Biotechnol 2006;24:625-34. [PMID: 16763588 DOI: 10.1038/nbt0606-625] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Abstract Although investors remained cautious of public biotech companies in 2005, acquisitions and research partnerships were on the up. Collapse Key Words Collapse MESH Headings Biotechnology/economics Biotechnology/statistics & numerical data Biotechnology/trends Europe Income/statistics & numerical data Income/trends Industry/economics Industry/statistics & numerical data Industry/trends Public Sector/economics Public Sector/statistics & numerical data United States Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Lähteenmäki R, Lawrence S. Public biotechnology 2005—the numbers. Nat Biotechnol 2006;24:625-34. [PMID: 16763588 DOI: 10.1038/nbt0606-625] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]